![]() Back to Annual Meeting
|
|
![]() Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
Jeannie Limpert, BS and Mary Pat McKay, MD, MPH. School of Medicine, The George Washington University, 2150 Pennsylvania Ave, NW Suite 2B, Department of Emergency Medicine ATTN: DR MCKAY, Washington, DC 20037, 202 741 2947, jlimpert@gwu.edu
Purpose: Describe the economics of fall injuries. Methods: Health Care Utilization Project data (state census of billing data from acute care, non-federal hospitals) was analyzed. Only Nebraska met study entry criteria: available data with better than 95% E-coding for both emergency department (ED)-only visits and inpatients. E-codes 880-888 defined falls. SPSS v14.0 calculated chi-squared or ANOVA as appropriate. Results: 30,711 of 332,602 ED-only visits had fallen (9.2%) with charges totaling $25,228,133 (8.7%). Mean charges for ED falls were less than non-falls ($822 vs. $867, p<0.001) and the patients were older than non-falls (p<0.001). Medicare ED falls patients were older and charged less than other Medicare ED patients (p<0.05). Of the 181,588 hospital admissions, 6,333 were falls (3.5%), with charges totaling $130,714,943 (4%). Mean charges for falls were higher than for non-injury visits ($20,460 vs $15,068, p<0.01). Falls had higher charges than non-falls except if the payer was Medicare, where charges were lower (p<0.05). Patients admitted for falls or other injuries were more likely to die while in the hospital than uninjured patients (3.1% vs. 1.9%, p<0.05). Falls survivors were more likely to be discharged to an inpatient source of care (55.3% vs. 12.8% non-falls, p <0.01). Conclusions: In Nebraska in 2004, fall injuries comprised $155, 943,076 in hospital charges; 4.4% of total statewide hospital charges. Fall injuries account for a disproportionate amount of hospital charges. If admitted, fall patients were much more likely to continue to require ongoing inpatient care.
Learning Objectives:
Keywords: Epidemiology, Economic Analysis
Presenting author's disclosure statement:
Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
The 135th APHA Annual Meeting & Exposition (November 3-7, 2007) of APHA